Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-009535
Filing Date
2021-04-23
Accepted
2021-04-23 14:24:49
Documents
68
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2858222
2 ex4-1.htm EX-4.1 53137
3 ex10-5.htm EX-10.5 204589
4 ex21.htm EX-21 4687
5 ex31-1.htm EX-31.1 15124
6 ex31-2.htm EX-31.2 15106
7 ex32-1.htm EX-32.1 9128
8 logo_001.jpg GRAPHIC 4176
9 form10-k_001.jpg GRAPHIC 15943
10 form10-k_002.jpg GRAPHIC 26254
11 form10-k_003.jpg GRAPHIC 40487
12 form10-k_004.jpg GRAPHIC 21809
  Complete submission text file 0001493152-21-009535.txt   6854755

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE FILE crxm-20191231.xml EX-101.INS 806748
14 XBRL SCHEMA FILE crxm-20191231.xsd EX-101.SCH 42365
15 XBRL CALCULATION FILE crxm-20191231_cal.xml EX-101.CAL 54011
16 XBRL DEFINITION FILE crxm-20191231_def.xml EX-101.DEF 198530
17 XBRL LABEL FILE crxm-20191231_lab.xml EX-101.LAB 337557
18 XBRL PRESENTATION FILE crxm-20191231_pre.xml EX-101.PRE 276185
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Gene Biotherapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

EIN.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33635 | Film No.: 21848899
SIC: 2836 Biological Products, (No Diagnostic Substances)